Visual Processing Speed: Clinical Trials

2 trials for Visual Processing Speed, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Not yet recruiting 1

Follow Visual Processing Speed: new trials by email Literature Review of Visual Processing Speed trials Research Report on Visual Processing Speed

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effectiveness of AV-stimulation in Immersive VR to Improve Visual Perception and Driving Performance
Audiovisual Stimulation - Stroke, Visual Impairment
Not applicableNot yet recruitingUniversity Health Network, Toronto302025-02-012024-12-19
Iowa Healthy and Active Minds Study
SOPT basic training, Crossword Puzzles, SOPT booster training - Visual Processing Speed
Not applicableCompletedFredric D Wolinsky6812009-09-012019-06-21

Narrower conditions

Cognitive Dysfunction (1)  ·  Spatial Processing (1)  ·  Stroke (1)  ·  Vision Disorders (1)  ·  Vision, Low (1)

Broader conditions

Behavior (1)  ·  Brain Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Cognition Disorders (1)  ·  Eye Diseases (1)  ·  Mental Disorders (1)  ·  Nervous System Diseases (1)  ·  Neurocognitive Disorders (1)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Sensation Disorders (1)  ·  Signs and Symptoms (1)  ·  Spatial Behavior (1)

Sponsors

Fredric D Wolinsky (1)  ·  University Health Network, Toronto (1)

Countries

Canada (1)  ·  United States (1)

Top investigators

Fredric D Wolinksy, Ph.D. (1)  ·  Jennifer Campos, PhD (1)  ·  Lora Appel, PhD (1)  ·  Michael Reber, PhD (1)

Results publications

PMID 17027061, PMID 22106377, PMID 23650501, PMID 25239928, PMID 26364892, PMID 32300295

NIH funding

1RC1AG035546-01 (1)